2,765
Views
76
CrossRef citations to date
0
Altmetric
Review

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology

, , &
Pages 1-6 | Received 18 Feb 2017, Accepted 17 Apr 2017, Published online: 15 Jan 2019

References

  • Dick GW, Kitchen SF, Haddow AJ.Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952;46: 509–520.
  • Dick GW.Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 1952;46: 521–534.
  • Simpson DI.Zika virus infection in man. Trans R Soc Trop Med Hyg 1964;58: 335–338.
  • Moore DL, Causey OR, Carey DEet al.Arthropod-borne viral infections of man in Nigeria, 1964–1970. Ann Trop Med Parasitol 1975;69: 49–64.
  • Fagbami AH.Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 1979;83: 213–219.
  • Olson JG, Ksiazek TG, Suhandiman, Triwibowo.Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981;75: 389–393.
  • Musso D, Gubler DJ.Zika virus. Clin Microbiol Rev 2016;29: 487–524.
  • Wikan N, Smith DR.Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis 2016;16: e119–e126.
  • Duffy MR, Chen TH, Hancock WTet al.Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360: 2536–2543.
  • Lanciotti RS, Kosoy OL, Laven JJet al.Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14: 1232–1239.
  • Cao-Lormeau VM, Roche C, Teissier Aet al.Zika virus, French polynesia, South Pacific, 2013. Emerg Infect Dis 2014;20: 1085–1086.
  • Roth A, Mercier A, Lepers Cet al.Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014. Euro Surveill 2014;19: 20929.
  • Oehler E, Watrin L, Larre Pet al.Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill 2014;19: 20720.
  • Cao-Lormeau VM, Blake A, Mons Set al.Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387: 531–1539.
  • Campos GS, Bandeira AC, Sardi SI.Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015;21: 1885–1886.
  • Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K.First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 2015;110: 569–572.
  • Cardoso CW, Paploski IA, Kikuti Met al.Outbreak of exanthematous illness associated with Zika, chikungunya, and dengue viruses, Salvador, Brazil. Emerg Infect Dis 2015;21: 2274–2276.
  • PAHO/WHO. Regional Zika epidemiological update (Americas) March 10 2017. Washington, DC: PAHO/WHO, 2016. Available at http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=38610&lang=en. (accessed 21 March 2017).
  • Likos A, Griffin I, Bingham AMet al.Local mosquito-borne transmission of Zika virus - Miami-Dade and Broward Counties, Florida.2016MMWR Morb Mortal Wkly Rep 2016;65: 1032–1038.
  • de Paula Freitas B, de Oliveira Dias JR, Prazeres Jet al.Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol 2016;134: 529–535.
  • Mlakar J, Korva M, Tul Net al.Zika virus associated with microcephaly. N Engl J Med 2016;374: 951–958.
  • Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R Jr.Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 2016;387: 228.
  • Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WTet al.Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65: 242–247.
  • Martines RB, Bhatnagar J, Keating MKet al.Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65: 159–160.
  • Driggers RW, Ho CY, Korhonen EMet al.Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016;374: 2142–2151.
  • Calvet G, Aguiar RS, Melo ASet al.Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016;16: 653–660.
  • Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR.Zika virus and birth defects - reviewing the evidence for causality. N Engl J Med 2016;374: 1981–1987.
  • Bhatt S, Gething PW, Brady OJet al.The global distribution and burden of dengue. Nature 2013;496: 504–507.
  • Stanaway JD, Shepard DS, Undurraga EAet al.The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 2016;16: 712–723.
  • Sirohi D, Chen Z, Sun Let al.The 3.8A resolution cryo-EM structure of Zika virus. Science 2016;352: 467–470.
  • Prasad VM, Miller AS, Klose Tet al.Structure of the immature Zika virus at 9A resolution. Nat Struct Mol Biol 2017;24: 184–186.
  • Priyamvada L, Quicke KM, Hudson WHet al.Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci USA 2016;113: 7852–7857.
  • Stettler K, Beltramello M, Espinosa DAet al.Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 2016;353: 823–826.
  • Ye Q, Liu ZY, Han JF, Jiang T, Li XF, Qin CF.Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infect Genet Evol 2016;43: 43–49.
  • Dai L, Song J, Lu Xet al.Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 2016;19: 696–704.
  • Sukupolvi-Petty S, Austin SK, Purtha WEet al.Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 2007;81: 12816–12826.
  • Shrestha B, Brien JD, Sukupolvi-Petty Set al.The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog 2010;6: e1000823.
  • Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva MA.Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 2009;392: 103–113.
  • Midgley CM, Bajwa-Joseph M, Vasanawathana Set al.An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 2011;85: 410–421.
  • Dejnirattisai W, Wongwiwat W, Supasa Set al.A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol 2015;16: 170–177.
  • de Alwis R, Smith SA, Olivarez NPet al.Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci USA 2012;109: 7439–7444.
  • Teoh EP, Kukkaro P, Teo EWet al.The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med 2012;4: 139ra183.
  • Fibriansah G, Tan JL, Smith SAet al.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun 2015;6: 6341.
  • Fibriansah G, Ibarra KD, Ng TSet al.Dengue virus. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 2015;349: 88–91.
  • Wang Q, Yang H, Liu Xet al.Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci Transl Med 2016;8: 369ra179.
  • Sapparapu G, Fernandez E, Kose Net al.Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 2016;540: 443–447.
  • Swanstrom JA, Plante JA, Plante KSet al.Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika VIrus. MBio 2016;7: e01123–16.
  • Dejnirattisai W, Supasa P, Wongwiwat Wet al.Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016;17: 1102–1108.
  • Durand MA, Bel M, Ruwey I, Marfel M, Yug L, Ngaden V.An outbreak of dengue fever in Yap State. Pac Health Dialog 2005;12: 99–102.
  • Cao-Lormeau VM, Roche C, Aubry Met al.Recent emergence of dengue virus serotype 4 in French Polynesia results from multiple introductions from other South Pacific Islands. PLoS One 2011;6: e29555.
  • Cao-Lormeau VM, Musso D.Emerging arboviruses in the Pacific. Lancet 2014;384: 1571–1572.
  • Singh N, Kiedrzynski T, Lepers C, Benyon EK.Dengue in the Pacific—an update of the current situation. Pac Health Dialog 2005;12: 111–119.
  • Aubry M, Finke J, Teissier Aet al.Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis 2015;41: 11–12.
  • Beltramello M, Williams KL, Simmons CPet al.The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010;8: 271–283.
  • Vaughan K, Greenbaum J, Blythe M, Peters B, Sette A.Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol 2010;23: 259–284.
  • Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE Jr.Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol 2012;86: 2665–2675.
  • Friberg H, Jaiswal S, West K, O'Ketch M, Rothman AL, Mathew A.Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells. Viral Immunol 2012;25: 348–359.
  • Dejnirattisai W, Jumnainsong A, Onsirisakul Net al.Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010;328: 745–748.
  • Xu M, Hadinoto V, Appanna Ret al.Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J Immunol 2012;189: 5877–5885.
  • Priyamvada L, Cho A, Onlamoon Net al.B cell responses during secondary dengue infection are dominated by highly cross-reactive, memory-derived plasmablasts. J Virol 2016;90: 5574–5585.
  • Barba-Spaeth G, Dejnirattisai W, Rouvinski Aet al.Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 2016;536: 48–53.
  • Halstead SB.Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003;60: 421–467.
  • Vaughn DW, Green S, Kalayanarooj Set al.Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181: 2–9.
  • Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS.Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989;40: 444–451.
  • Zhao H, Fernandez E, Dowd KAet al.Structural basis of Zika virus-specific antibody protection. Cell 2016;166: 1016–1027.
  • PAHO/WHO Zika cases and congenital syndrome associated with Zika virus reported by countries and terriroties in the Americas, 2015-2016 Cumulative cases. Washington, DC: PAHO/WHO, 2016. Available at http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=37582&lang=en (accessed 21 March 2017).
  • Kumar S, Stecher G, Tamura K.MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016;33: 1870–1874.
  • Jones DT, Taylor WR, Thornton JM.The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 1992;8: 275–282.
  • Wickham H. ggplot2: Elegant Graphics For Data Analysis.New York: Springer, 2009.
  • Kearse M, Moir R, Wilson Aet al.Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012;28: 1647–1649.
  • Rouvinski A, Guardado-Calvo P, Barba-Spaeth Get al.Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 2015;520: 109–113.